Title: Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome.
Journal: European journal of endocrinology 20150601
Title: Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.
Journal: Pituitary 20150401
Title: Medical treatment of Cushing disease: new targets, new hope.
Journal: Endocrinology and metabolism clinics of North America 20150301
Title: Efficacy and safety of LCI699 for hypertension: a meta-analysis of randomized controlled trials and systematic review.
Journal: European review for medical and pharmacological sciences 20150101
Title: Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
Journal: Journal of medicinal chemistry 20140626
Title: The effects of aldosterone synthase inhibition on aldosterone and cortisol in patients with hypertension: a phase II, randomized, double-blind, placebo-controlled, multicenter study.
Journal: Journal of clinical hypertension (Greenwich, Conn.) 20120901
Title: Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.
Journal: Circulation 20111101
Title: Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.
Journal: Hypertension (Dallas, Tex. : 1979) 20101101
Title: Ménard J, et, al. Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects. J Transl Med. 2014 Dec 10;12:340.
Title: Creemers SG, et, al. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3437-3449.
Title: Li L, et, al. Osilodrostat (LCI699), a potent 11β-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats. Toxicol Appl Pharmacol. 2015 Aug 1;286(3):224-33.
